The incidence of myopericarditis in patients with COVID-19
Introduction: SARS-COV-2 can affect different organ systems, including the cardiovascular system with wide spectrum of clinical presentations including the thrombotic complications, acute cardiovascular injury and myopericarditis. There is limited study regarding COVID-19 and myopericarditis. The ai...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tabriz University of Medical Sciences
2021-08-01
|
| Series: | Journal of Cardiovascular and Thoracic Research |
| Subjects: | |
| Online Access: | https://jcvtr.tbzmed.ac.ir/PDF/jcvtr-13-203.pdf |
| _version_ | 1818656320350322688 |
|---|---|
| author | Atoosa Mostafavi Seyed Abdol Hussein Tabatabaei Somayeh Zamani Fard Fatemeh Majidi Abbas Mohagheghi Shahin Shirani |
| author_facet | Atoosa Mostafavi Seyed Abdol Hussein Tabatabaei Somayeh Zamani Fard Fatemeh Majidi Abbas Mohagheghi Shahin Shirani |
| author_sort | Atoosa Mostafavi |
| collection | DOAJ |
| description | Introduction: SARS-COV-2 can affect different organ systems, including the cardiovascular system with wide spectrum of clinical presentations including the thrombotic complications, acute cardiovascular injury and myopericarditis. There is limited study regarding COVID-19 and myopericarditis. The aim of this study was to evaluate myopericarditis in patients with definite diagnosis of COVID-19. Methods: In this observational study we analyzed the admitted patients with definite diagnosis of COVID-19 based on positive RT-PCR test. Laboratory data, and ECG changes on days 1-3-5 were analyzed for sign of pericarditis and also QT interval prolongation. Echocardiography was performed on days 2-4 and repeated as necessary, and one month after discharge for possible late presentation of symptom. Any patient with pleuritic chest pain, and pericardial effusion and some rise in cardiac troponin were considered as myopericarditis. Results: A total of 404 patients (18-90 years old, median =63, 273 males and 131 females) with definite diagnosis of COVID-19 were enrolled in the study. Five patients developed in-hospital pleuritic chest pain with mild left ventricular dysfunction and mild pericardial effusion and diagnosed as myopericarditis, none of them proceed to cardiac tamponade. We found no case of late myopericarditis. Conclusion: Myopericarditis, pericardial effusion and cardiac tamponade are rare complication of COVID-19 with prevalence about 1.2 %, but should be considered as a possible cause of hemodynamic deterioration. |
| first_indexed | 2024-12-17T03:23:43Z |
| format | Article |
| id | doaj.art-182ff84a9978402a932e5d9df2eac1dc |
| institution | Directory Open Access Journal |
| issn | 2008-5117 2008-6830 |
| language | English |
| last_indexed | 2024-12-17T03:23:43Z |
| publishDate | 2021-08-01 |
| publisher | Tabriz University of Medical Sciences |
| record_format | Article |
| series | Journal of Cardiovascular and Thoracic Research |
| spelling | doaj.art-182ff84a9978402a932e5d9df2eac1dc2022-12-21T22:05:27ZengTabriz University of Medical SciencesJournal of Cardiovascular and Thoracic Research2008-51172008-68302021-08-0113320320710.34172/jcvtr.2021.36jcvtr-30235The incidence of myopericarditis in patients with COVID-19Atoosa Mostafavi0Seyed Abdol Hussein Tabatabaei1Somayeh Zamani Fard2Fatemeh Majidi3Abbas Mohagheghi4Shahin Shirani5Department of Cardiology, Tehran University of Medical Science, Dr Ali Shariati Hospital, Tehran, IranDepartment of Cardiology, Tehran University of Medical Science, Dr Ali Shariati Hospital, Tehran, IranDepartment of Cardiology, Tehran University of Medical Science, Dr Ali Shariati Hospital, Tehran, IranDepartment of Cardiology, Tehran University of Medical Science, Dr Ali Shariati Hospital, Tehran, IranDepartment of Cardiology, Tehran University of Medical Science, Dr Ali Shariati Hospital, Tehran, IranDepartment of Cardiology, Tehran University of Medical Science, Dr Ali Shariati Hospital, Tehran, IranIntroduction: SARS-COV-2 can affect different organ systems, including the cardiovascular system with wide spectrum of clinical presentations including the thrombotic complications, acute cardiovascular injury and myopericarditis. There is limited study regarding COVID-19 and myopericarditis. The aim of this study was to evaluate myopericarditis in patients with definite diagnosis of COVID-19. Methods: In this observational study we analyzed the admitted patients with definite diagnosis of COVID-19 based on positive RT-PCR test. Laboratory data, and ECG changes on days 1-3-5 were analyzed for sign of pericarditis and also QT interval prolongation. Echocardiography was performed on days 2-4 and repeated as necessary, and one month after discharge for possible late presentation of symptom. Any patient with pleuritic chest pain, and pericardial effusion and some rise in cardiac troponin were considered as myopericarditis. Results: A total of 404 patients (18-90 years old, median =63, 273 males and 131 females) with definite diagnosis of COVID-19 were enrolled in the study. Five patients developed in-hospital pleuritic chest pain with mild left ventricular dysfunction and mild pericardial effusion and diagnosed as myopericarditis, none of them proceed to cardiac tamponade. We found no case of late myopericarditis. Conclusion: Myopericarditis, pericardial effusion and cardiac tamponade are rare complication of COVID-19 with prevalence about 1.2 %, but should be considered as a possible cause of hemodynamic deterioration.https://jcvtr.tbzmed.ac.ir/PDF/jcvtr-13-203.pdfpericarditispericardial effusionmyocarditismyopericarditiscovid-19sars-cov-2 |
| spellingShingle | Atoosa Mostafavi Seyed Abdol Hussein Tabatabaei Somayeh Zamani Fard Fatemeh Majidi Abbas Mohagheghi Shahin Shirani The incidence of myopericarditis in patients with COVID-19 Journal of Cardiovascular and Thoracic Research pericarditis pericardial effusion myocarditis myopericarditis covid-19 sars-cov-2 |
| title | The incidence of myopericarditis in patients with COVID-19 |
| title_full | The incidence of myopericarditis in patients with COVID-19 |
| title_fullStr | The incidence of myopericarditis in patients with COVID-19 |
| title_full_unstemmed | The incidence of myopericarditis in patients with COVID-19 |
| title_short | The incidence of myopericarditis in patients with COVID-19 |
| title_sort | incidence of myopericarditis in patients with covid 19 |
| topic | pericarditis pericardial effusion myocarditis myopericarditis covid-19 sars-cov-2 |
| url | https://jcvtr.tbzmed.ac.ir/PDF/jcvtr-13-203.pdf |
| work_keys_str_mv | AT atoosamostafavi theincidenceofmyopericarditisinpatientswithcovid19 AT seyedabdolhusseintabatabaei theincidenceofmyopericarditisinpatientswithcovid19 AT somayehzamanifard theincidenceofmyopericarditisinpatientswithcovid19 AT fatemehmajidi theincidenceofmyopericarditisinpatientswithcovid19 AT abbasmohagheghi theincidenceofmyopericarditisinpatientswithcovid19 AT shahinshirani theincidenceofmyopericarditisinpatientswithcovid19 AT atoosamostafavi incidenceofmyopericarditisinpatientswithcovid19 AT seyedabdolhusseintabatabaei incidenceofmyopericarditisinpatientswithcovid19 AT somayehzamanifard incidenceofmyopericarditisinpatientswithcovid19 AT fatemehmajidi incidenceofmyopericarditisinpatientswithcovid19 AT abbasmohagheghi incidenceofmyopericarditisinpatientswithcovid19 AT shahinshirani incidenceofmyopericarditisinpatientswithcovid19 |